Trading BioPhama stocks before a catalyst event, if done correctly can be a very profitable proposition, but if traded in a wrong manner, can cause losses. I remarked in an article from March of this year that Horizon Pharma (NASDAQ:…
Trading BioPhama stocks before a catalyst event, if done correctly can be a very profitable proposition, but if traded in a wrong manner, can cause losses. I remarked in an article from March of this year that Horizon Pharma (NASDAQ:…
